Daily Med News

Experimental Alzheimer’s Drug, Donanemab, Slows Thinking Declines in Late-Stage Trial

MONDAY, July 17, 2023 — Another experimental drug meant to slow the damage of Alzheimer’s appears poised to join a growing arsenal of new treatments for this memory-robbing disease.
In research published online Monday in the Journal of the…

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]